• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制动相关高钙血症——一种可能的新机制及对帕米膦酸二钠的反应

Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.

作者信息

Gallacher S J, Ralston S H, Dryburgh F J, Logue F C, Allam B F, Boyce B F, Boyle I T

机构信息

University Department of Medicine, Glasgow Royal Infirmary, UK.

出版信息

Postgrad Med J. 1990 Nov;66(781):918-22. doi: 10.1136/pgmj.66.781.918.

DOI:10.1136/pgmj.66.781.918
PMID:2267202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2429738/
Abstract

Immobilization-related hypercalcaemia is an uncommon but important condition being associated not infrequently with both urolithiasis and osteoporosis. In this study 5 patients who had been immobilized for a mean of 3 months and had a mean adjusted serum calcium of 3.15 mmol/l were treated with doses of intravenous pamidronate ranging between 10 mg and 45 mg. All patients became normocalcaemic by day 3. Patients 1-3 mobilized shortly after treatment and remained normocalcaemic. In those patients who continued to be immobile hypercalcaemia recurred after an interval of several weeks. Retreatment with pamidronate again resulted in normocalcaemia. No side effects were noted with treatment. All of the patients studied had increased rates of bone resorption as shown by elevated urinary hydroxyproline/creatinine ratios (median:range) of 0.101:0.045-0.180 (normal less than 0.033) and elevated calcium/creatinine ratios of 2.50:0.69-3.63 (normal less than 0.50). None of the patients in this study had any of the usual risk factors for developing immobilization-related hypercalcaemia though all 5 patients had problems with significant sepsis which we postulate may have lead to cytokine release which in turn contributed to the development of hypercalcaemia. We conclude that pamidronate (at doses as low as 10 mg) is safe and effective in immobilization-related hypercalcaemia and suggest that sepsis should be added to the list of risk factors for development of this syndrome.

摘要

制动相关的高钙血症是一种不常见但很重要的病症,常与尿路结石和骨质疏松症相关。在本研究中,5例平均制动3个月且平均校正血清钙为3.15 mmol/L的患者接受了剂量为10 mg至45 mg的静脉注射帕米膦酸盐治疗。所有患者在第3天时血钙恢复正常。患者1至3在治疗后不久即可活动,且血钙保持正常。在那些持续不能活动的患者中,数周后高钙血症复发。再次用帕米膦酸盐治疗后血钙又恢复正常。治疗过程中未观察到副作用。所有研究患者的骨吸收速率均增加,表现为尿羟脯氨酸/肌酐比值(中位数:范围)升高,为0.101:0.045 - 0.180(正常小于0.033),钙/肌酐比值升高,为2.50:0.69 - 3.63(正常小于0.50)。本研究中的患者均无发生制动相关高钙血症的常见危险因素,尽管所有5例患者均有严重脓毒症问题,我们推测这可能导致细胞因子释放,进而促成了高钙血症的发生。我们得出结论,帕米膦酸盐(低至10 mg的剂量)在制动相关高钙血症中安全有效,并建议脓毒症应被列入该综合征发生的危险因素清单。

相似文献

1
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.制动相关高钙血症——一种可能的新机制及对帕米膦酸二钠的反应
Postgrad Med J. 1990 Nov;66(781):918-22. doi: 10.1136/pgmj.66.781.918.
2
Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.静脉注射帕米膦酸钠治疗有效的制动后高钙血症
Postgrad Med J. 1989 Apr;65(762):244-6. doi: 10.1136/pgmj.65.762.244.
3
A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia.低剂量与高剂量帕米膦酸盐治疗癌症相关性高钙血症的比较。
Bone Miner. 1991 Dec;15(3):249-56. doi: 10.1016/0169-6009(91)90130-r.
4
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.静脉注射帕米膦酸盐和氯膦酸盐治疗恶性肿瘤高钙血症的随机双盲对照研究
Br J Cancer. 1995 Nov;72(5):1289-93. doi: 10.1038/bjc.1995.502.
5
Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
Clin Rheumatol. 1991 Sep;10(3):328-32. doi: 10.1007/BF02208702.
6
Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type.用双膦酸盐帕米膦酸治疗肿瘤引起的高钙血症:剂量反应关系及肿瘤类型的影响。
Ann Oncol. 1994 Apr;5(4):359-63. doi: 10.1093/oxfordjournals.annonc.a058841.
7
Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy.恶性肿瘤高钙血症患者帕米膦酸二钠的最佳给药频率
Clin Endocrinol (Oxf). 1994 Nov;41(5):591-5. doi: 10.1111/j.1365-2265.1994.tb01823.x.
8
Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.维生素D中毒通过增加骨吸收导致高钙血症,而骨吸收对帕米膦酸盐有反应。
Clin Endocrinol (Oxf). 1995 Nov;43(5):531-6. doi: 10.1111/j.1365-2265.1995.tb02916.x.
9
Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
Scand J Urol Nephrol. 1993;27(4):447-51. doi: 10.3109/00365599309182276.
10
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.对骨Paget病和恶性肿瘤高钙血症中甲状旁腺激素对帕米膦酸盐治疗反应的直接和间接评估。
Bone Miner. 1991 Feb;12(2):113-21. doi: 10.1016/0169-6009(91)90040-7.

引用本文的文献

1
Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.地舒单抗治疗晚期肾衰竭患者固定相关高钙血症。
Clin Kidney J. 2012 Dec;5(6):566-71. doi: 10.1093/ckj/sfs116. Epub 2012 Oct 7.
2
At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.鉴别诊断清单的末尾:儿童高血压的罕见病因。
Pediatr Nephrol. 2009 Nov;24(11):2137-46. doi: 10.1007/s00467-008-0744-y. Epub 2008 Mar 5.
3
Pamidronate treatment in acute vitamin D intoxication.急性维生素D中毒的帕米膦酸盐治疗
J Endocrinol Invest. 2004 Jul-Aug;27(7):680-2. doi: 10.1007/BF03347503.
4
Pamidronate: an unrecognized problem in gastrointestinal tolerability.
Osteoporos Int. 1994 Nov;4(6):320-2. doi: 10.1007/BF01622190.
5
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.帕米膦酸盐。其药理学特性及在溶骨性骨病中治疗效果的综述。
Drugs. 1991 Feb;41(2):289-318. doi: 10.2165/00003495-199141020-00009.
6
Severe hypercalcaemia four months after acute oliguric renal failure--successful treatment with intravenous clodronate.急性少尿性肾衰竭四个月后出现严重高钙血症——静脉注射氯膦酸盐治疗成功
Ir J Med Sci. 1992 Jun;161(6):414-6. doi: 10.1007/BF02996206.

本文引用的文献

1
THE INFLUENCE OF IMMOBILISATION ON BONE FORMATION AS EVALUATED BY OSSEOUS INCORPORATION OF TETRACYCLINES.通过四环素骨结合评估固定对骨形成的影响。
J Bone Joint Surg Br. 1964 Nov;46:764-71.
2
Radiocalcium metabolism in disuse osteoporosis in man.人体废用性骨质疏松症中的放射性钙代谢
Am J Med. 1962 Aug;33:188-200. doi: 10.1016/0002-9343(62)90017-7.
3
Predictive value of derived calcium figures based on the measurement of ionised calcium.基于离子钙测量得出的衍生钙数值的预测价值。
Ann Clin Biochem. 1981 Mar;18 (Pt 2):106-9. doi: 10.1177/000456328101800210.
4
Pre-operative localisation of parathyroid tumours using neck vein catheterisation and radioimmunoassay for parathyroid hormone: the Glasgow experience.使用颈静脉插管和甲状旁腺激素放射免疫测定法对甲状旁腺肿瘤进行术前定位:格拉斯哥经验
Scott Med J. 1983 Apr;28(2):146-52. doi: 10.1177/003693308302800210.
5
Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys.猴子废用性骨质疏松中椎体与外周矿物质丢失的比较。
Radiology. 1980 Feb;134(2):525-9. doi: 10.1148/radiology.134.2.6766220.
6
Circulating vitamin D metabolites and hypercalcaemia of malignancy.循环维生素D代谢产物与恶性肿瘤高钙血症
Acta Endocrinol (Copenh). 1984 Aug;106(4):556-63. doi: 10.1530/acta.0.1060556.
7
Immobilisation hypercalcaemia in adults and treatment with clodronate.成人制动后高钙血症及氯膦酸盐治疗
Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1111-2. doi: 10.1136/bmj.289.6452.1111.
8
Effect of prolonged bed rest on urinary calcium output.
J Appl Physiol. 1966 May;21(3):1013-20. doi: 10.1152/jappl.1966.21.3.1013.
9
Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis.基于树脂催化水解的尿总羟脯氨酸常规检测
Clin Chim Acta. 1972 Oct;41:29-40. doi: 10.1016/0009-8981(72)90492-5.
10
Relation between serum and urinary calcium with particular reference to parathyroid activity.
Lancet. 1969 Feb 22;1(7591):384-6. doi: 10.1016/s0140-6736(69)91353-1.